Astrazeneca PLC ASTRAZENECA ADR REPRESENTING 0.5 ORD SHS
Astrazeneca PLC ASTRAZENECA ADR R.../ US0463531089 /
0A4J
|
2024. 05. 21. 14:40:24
|
Vált.
-
|
Forgalom (db) |
Vétel6:00:09 |
Eladás6:00:09 |
Piaci kapitalizáció |
Osztalékh. |
P/E Ráta |
|
77,60USD
|
-
|
24 812
Forgalom: 1,35 mill. |
-Vétel (db): - |
-Eladás (db): - |
199,37 mrd.USD |
- |
16,79 |
Cégbemutató
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Igazgatóság & Felügyelőbizottság
| CEO |
| Pascal Soriot |
| Igazgatóság |
| Aradhana Sarin, Pam Cheng, Ruud Dobber, Marc Dunoyer, David Fredrickson, Susan Galbraith, Jeff Pott, Iskra Reic, Leon Wang, Sharon Barr |
| Felügyelőbizottság |
| Michel Demaré, Pascal Soriot, Aradhana Sarin, Philip Broadley, Euan Ashley, Deborah DiSanzo, Diana Layfield, Sheri McCoy, Tony Mok, Nazneen Rahman, Andreas Rummelt, Marcus Wallenberg, Anna Manz |
